메뉴 건너뛰기




Volumn 20, Issue 6, 2014, Pages 27-35

Antifungal pre-emptive strategy for high-risk neutropenic patients: Why the story is still ongoing

Author keywords

Empirical antifungal therapy; Fungal PCR; Galactomannan; Invasive fungal disease; Invasive fungal infection; Neutropenia; Pre emptive antifungal therapy

Indexed keywords

ANTIFUNGAL AGENT; BIOLOGICAL MARKER; GALACTOMANNAN;

EID: 84922275870     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12428     Document Type: Review
Times cited : (19)

References (60)
  • 2
    • 0037043655 scopus 로고    scopus 로고
    • Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    • Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
    • (2002) N Engl J Med , vol.347 , pp. 408-415
    • Herbrecht, R.1    Denning, D.W.2    Patterson, T.F.3
  • 3
    • 53349171951 scopus 로고    scopus 로고
    • Factors associated with overall and attributable mortality in invasive aspergillosis
    • Nivoix Y, Velten M, Letscher-Bru V et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47: 1176-1184.
    • (2008) Clin Infect Dis , vol.47 , pp. 1176-1184
    • Nivoix, Y.1    Velten, M.2    Letscher-Bru, V.3
  • 4
    • 34848928703 scopus 로고    scopus 로고
    • Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
    • Pappas PG, Rotstein CM, Betts RF et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007; 45: 883-893.
    • (2007) Clin Infect Dis , vol.45 , pp. 883-893
    • Pappas, P.G.1    Rotstein, C.M.2    Betts, R.F.3
  • 5
    • 34247564562 scopus 로고    scopus 로고
    • Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
    • Kuse ER, Chetchotisakd P, da Cunha CA et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369: 1519-1527.
    • (2007) Lancet , vol.369 , pp. 1519-1527
    • Kuse, E.R.1    Chetchotisakd, P.2    da Cunha, C.A.3
  • 6
    • 79551617211 scopus 로고    scopus 로고
    • Impact of invasive fungal infection on the chemotherapy schedule and event-free survival in acute leukemia patients who survive to invasive fungal infection: a case- control study
    • Even C, Bastuji-Garin S, Hicheri Y et al. Impact of invasive fungal infection on the chemotherapy schedule and event-free survival in acute leukemia patients who survive to invasive fungal infection: a case- control study. Haematologica 2011; 96: 337-341.
    • (2011) Haematologica , vol.96 , pp. 337-341
    • Even, C.1    Bastuji-Garin, S.2    Hicheri, Y.3
  • 7
    • 0024371959 scopus 로고
    • Empiric antifungal therapy in febrile granulocytopenic patients
    • EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668-672.
    • (1989) Am J Med , vol.86 , pp. 668-672
  • 8
    • 0019946004 scopus 로고
    • Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
    • Pizzo P, Robichaud KJ, Gill FA, Witebsky FG. Empirical antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101-111.
    • (1982) Am J Med , vol.72 , pp. 101-111
    • Pizzo, P.1    Robichaud, K.J.2    Gill, F.A.3    Witebsky, F.G.4
  • 9
    • 33745792967 scopus 로고    scopus 로고
    • Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)
    • Chamilos G, Luna M, Lewis R et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-989.
    • (2006) Haematologica , vol.91 , pp. 986-989
    • Chamilos, G.1    Luna, M.2    Lewis, R.3
  • 10
    • 84886306657 scopus 로고    scopus 로고
    • Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study
    • Lewis R, Cahyame-Zuniga L, Leventakos K et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 2013; 56: 638-645.
    • (2013) Mycoses , vol.56 , pp. 638-645
    • Lewis, R.1    Cahyame-Zuniga, L.2    Leventakos, K.3
  • 11
    • 0036532203 scopus 로고    scopus 로고
    • Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
    • Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
    • (2002) Clin Infect Dis , vol.34 , pp. 909-917
    • Marr, K.A.1    Carter, R.A.2    Crippa, F.3    Wald, A.4    Corey, L.5
  • 12
    • 77950682818 scopus 로고    scopus 로고
    • Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study
    • Pagano L, Caira M, Candoni A et al. Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica 2010; 22: 644-650.
    • (2010) Haematologica , vol.22 , pp. 644-650
    • Pagano, L.1    Caira, M.2    Candoni, A.3
  • 13
    • 0013877409 scopus 로고
    • Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
    • Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
    • (1966) Ann Intern Med , vol.64 , pp. 328-340
    • Bodey, G.P.1    Buckley, M.2    Sathe, Y.S.3    Freireich, E.J.4
  • 14
    • 0842307151 scopus 로고    scopus 로고
    • Empirical antifungal therapy
    • Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents 2004; 23: 105-112.
    • (2004) Int J Antimicrob Agents , vol.23 , pp. 105-112
    • Klastersky, J.1
  • 15
    • 34547546151 scopus 로고    scopus 로고
    • Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
    • Marchetti O, Cordonnier C, Calandra T. Empirical antifungal therapy in neutropaenic cancer patients with persistent fever. Eur J Cancer 2007; S5: 32-42.
    • (2007) Eur J Cancer , vol.S5 , pp. 32-42
    • Marchetti, O.1    Cordonnier, C.2    Calandra, T.3
  • 16
    • 48749096676 scopus 로고    scopus 로고
    • Delaying amphotericin-B based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis
    • Chamilos G, Lewis R, Kontoyiannis D. Delaying amphotericin-B based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-509.
    • (2008) Clin Infect Dis , vol.47 , pp. 503-509
    • Chamilos, G.1    Lewis, R.2    Kontoyiannis, D.3
  • 17
    • 0028827035 scopus 로고
    • Pulmonary aspergillosis: early diagnosis improves survival
    • von EiffEM, Roos N, Schulten R et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341-347.
    • (1995) Respiration , vol.62 , pp. 341-347
    • von Eiff, E.M.1    Roos, N.2    Schulten, R.3
  • 18
    • 0033545538 scopus 로고    scopus 로고
    • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
    • Walsh TJ, Finberg RW, Arndt C et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340: 764-771.
    • (1999) N Engl J Med , vol.340 , pp. 764-771
    • Walsh, T.J.1    Finberg, R.W.2    Arndt, C.3
  • 19
    • 0037165259 scopus 로고    scopus 로고
    • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
    • Walsh TJ, Pappas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-234.
    • (2002) N Engl J Med , vol.346 , pp. 225-234
    • Walsh, T.J.1    Pappas, P.2    Winston, D.J.3
  • 20
    • 4644346490 scopus 로고    scopus 로고
    • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
    • Walsh TJ, Teppler H, Donowitz GR et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-1402.
    • (2004) N Engl J Med , vol.351 , pp. 1391-1402
    • Walsh, T.J.1    Teppler, H.2    Donowitz, G.R.3
  • 21
    • 9844239388 scopus 로고    scopus 로고
    • A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
    • Prentice H, Hann I, Herbrecht R et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 1997; 98: 711-718.
    • (1997) Br J Haematol , vol.98 , pp. 711-718
    • Prentice, H.1    Hann, I.2    Herbrecht, R.3
  • 23
    • 0034456963 scopus 로고    scopus 로고
    • A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
    • Wingard JR, White MH, Anaissie E, Raffali J, Goodman J, Arrieta A. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31: 1155-1163.
    • (2000) Clin Infect Dis , vol.31 , pp. 1155-1163
    • Wingard, J.R.1    White, M.H.2    Anaissie, E.3    Raffali, J.4    Goodman, J.5    Arrieta, A.6
  • 24
    • 79951816939 scopus 로고    scopus 로고
    • Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America
    • Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52: e56-e93.
    • (2011) Clin Infect Dis , vol.52 , pp. e56-e93
    • Freifeld, A.G.1    Bow, E.J.2    Sepkowitz, K.A.3
  • 25
    • 84865422021 scopus 로고    scopus 로고
    • Azole preexposure affects the Aspergillus fumigatus population in patients
    • Alanio A, Cabaret O, Sitterle E et al. Azole preexposure affects the Aspergillus fumigatus population in patients. Antimicrob Agents Chemother 2012; 56: 4948-4950.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 4948-4950
    • Alanio, A.1    Cabaret, O.2    Sitterle, E.3
  • 26
    • 80755182326 scopus 로고    scopus 로고
    • Azole resistance in Aspergillus fumigatus-current epidemiology and future perspectives
    • Alanio A, Cordonnier C, Bretagne S. Azole resistance in Aspergillus fumigatus-current epidemiology and future perspectives. Current Fungal Infect Rep 2011; 5: 168-178.
    • (2011) Current Fungal Infect Rep , vol.5 , pp. 168-178
    • Alanio, A.1    Cordonnier, C.2    Bretagne, S.3
  • 27
    • 0029800728 scopus 로고    scopus 로고
    • Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
    • Boeckh M, Gooley T, Myerson D, Cunningham T, Schoch G, Bowden R. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063-4071.
    • (1996) Blood , vol.88 , pp. 4063-4071
    • Boeckh, M.1    Gooley, T.2    Myerson, D.3    Cunningham, T.4    Schoch, G.5    Bowden, R.6
  • 28
    • 51049108165 scopus 로고    scopus 로고
    • Management of CMV, HHV6, HHV7 and Kaposi-sarcoma herpesvirus infections in patients with hematological malignancies including stem cell transplantation
    • Ljungman P, De La Camara R, Cordonnier C et al. Management of CMV, HHV6, HHV7 and Kaposi-sarcoma herpesvirus infections in patients with hematological malignancies including stem cell transplantation. Bone Marrow Transplant 2008; 42: 227-240.
    • (2008) Bone Marrow Transplant , vol.42 , pp. 227-240
    • Ljungman, P.1    De La Camara, R.2    Cordonnier, C.3
  • 29
    • 0037090071 scopus 로고    scopus 로고
    • Definitions of cytomegalovirus infection and disease in transplant recipients
    • Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
    • (2002) Clin Infect Dis , vol.34 , pp. 1094-1097
    • Ljungman, P.1    Griffiths, P.2    Paya, C.3
  • 30
    • 78650210760 scopus 로고    scopus 로고
    • Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
    • Blenow O, Remberger M, Klingspor L et al. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1710-1718.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 1710-1718
    • Blenow, O.1    Remberger, M.2    Klingspor, L.3
  • 31
    • 63649156819 scopus 로고    scopus 로고
    • Empirical versus pre-emptive antifungal strategy in high-risk febrile neutropenic patients: a prospective randomized study
    • Cordonnier C, Pautas C, Maury S et al. Empirical versus pre-emptive antifungal strategy in high-risk febrile neutropenic patients: a prospective randomized study. Clin Infect Dis 2009; 48: 1042-1051.
    • (2009) Clin Infect Dis , vol.48 , pp. 1042-1051
    • Cordonnier, C.1    Pautas, C.2    Maury, S.3
  • 32
    • 64949149897 scopus 로고    scopus 로고
    • A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after Allo-SCT
    • Hebart H, Klingspor L, Klingebiel T et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after Allo-SCT. Bone Marrow Transplant 2009; 43: 553-561.
    • (2009) Bone Marrow Transplant , vol.43 , pp. 553-561
    • Hebart, H.1    Klingspor, L.2    Klingebiel, T.3
  • 33
    • 84878465978 scopus 로고    scopus 로고
    • Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk hematology patients: a randomised controlled trial
    • Morrissey O, Chen S, Sorrell T et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk hematology patients: a randomised controlled trial. Lancet Infect Dis 2013; 13: 519-528.
    • (2013) Lancet Infect Dis , vol.13 , pp. 519-528
    • Morrissey, O.1    Chen, S.2    Sorrell, T.3
  • 35
    • 26444584546 scopus 로고    scopus 로고
    • Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies
    • Weisser M, Rausch C, Simcock M et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis 2005; 41: 1143-1149.
    • (2005) Clin Infect Dis , vol.41 , pp. 1143-1149
    • Weisser, M.1    Rausch, C.2    Simcock, M.3
  • 36
    • 77950511957 scopus 로고    scopus 로고
    • Aspergillus PCR: one step closer towards standardisation
    • White P, Bretagne S, Klingspor L et al. Aspergillus PCR: one step closer towards standardisation. J Clin Microbiol 2010; 48: 1231-1240.
    • (2010) J Clin Microbiol , vol.48 , pp. 1231-1240
    • White, P.1    Bretagne, S.2    Klingspor, L.3
  • 37
    • 0021350050 scopus 로고
    • Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
    • Gerson S, Talbot G, Hurwitz S, Strom B, Lusk E, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345-351.
    • (1984) Ann Intern Med , vol.100 , pp. 345-351
    • Gerson, S.1    Talbot, G.2    Hurwitz, S.3    Strom, B.4    Lusk, E.5    Cassileth, P.A.6
  • 38
    • 17144403463 scopus 로고    scopus 로고
    • Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies
    • Muhlemann K, Wenger C, Zenhausern R, Tauber MG. Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies. Leukemia 2005; 19: 545-550.
    • (2005) Leukemia , vol.19 , pp. 545-550
    • Muhlemann, K.1    Wenger, C.2    Zenhausern, R.3    Tauber, M.G.4
  • 39
    • 84886634582 scopus 로고    scopus 로고
    • Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model
    • Schwarzinger M, Sagaon-Teyssier S, Cabaret O, Bretagne S, Cordonnier C. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model. PlosOne 2013; 8: e65776.
    • (2013) PlosOne , vol.8 , pp. e65776
    • Schwarzinger, M.1    Sagaon-Teyssier, S.2    Cabaret, O.3    Bretagne, S.4    Cordonnier, C.5
  • 40
    • 27444434378 scopus 로고    scopus 로고
    • Between over- and undertreatment of invasive fungal disease
    • De Pauw BE. Between over- and undertreatment of invasive fungal disease. Clin Infect Dis 2005; 41: 1251-1253.
    • (2005) Clin Infect Dis , vol.41 , pp. 1251-1253
    • De Pauw, B.E.1
  • 41
    • 27444447144 scopus 로고    scopus 로고
    • Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study
    • Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250.
    • (2005) Clin Infect Dis , vol.41 , pp. 1242-1250
    • Maertens, J.1    Theunissen, K.2    Verhoef, G.3
  • 42
    • 67651174360 scopus 로고    scopus 로고
    • An early CT-diagnosis based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality
    • Dignan FL, Evans SO, Ethell ME et al. An early CT-diagnosis based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplant 2009; 44: 51-56.
    • (2009) Bone Marrow Transplant , vol.44 , pp. 51-56
    • Dignan, F.L.1    Evans, S.O.2    Ethell, M.E.3
  • 43
    • 80052355809 scopus 로고    scopus 로고
    • The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-chart project
    • Pagano L, Caira M, Nosari A et al. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-chart project. Haematologica 2011; 96: 1366-1370.
    • (2011) Haematologica , vol.96 , pp. 1366-1370
    • Pagano, L.1    Caira, M.2    Nosari, A.3
  • 44
    • 75149154262 scopus 로고    scopus 로고
    • Empirical antifungal therapy in selected patients with persistent febrile neutropenia
    • Aguilar-Guisado M, Espigado I, Cordero E et al. Empirical antifungal therapy in selected patients with persistent febrile neutropenia. Bone Marrow Transplant 2010; 45: 159-164.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 159-164
    • Aguilar-Guisado, M.1    Espigado, I.2    Cordero, E.3
  • 45
    • 77449124531 scopus 로고    scopus 로고
    • Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study
    • Girmenia C, Micozzi A, Gentile G et al. Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study. J Clin Oncol 2010; 28: 667-674.
    • (2010) J Clin Oncol , vol.28 , pp. 667-674
    • Girmenia, C.1    Micozzi, A.2    Gentile, G.3
  • 46
    • 58349122651 scopus 로고    scopus 로고
    • Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
    • Barnes RA, White PL, Bygrave C, Evans N, Healy B, Kell J. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J Clin Pathol 2009; 62: 64-69.
    • (2009) J Clin Pathol , vol.62 , pp. 64-69
    • Barnes, R.A.1    White, P.L.2    Bygrave, C.3    Evans, N.4    Healy, B.5    Kell, J.6
  • 47
    • 0030978298 scopus 로고    scopus 로고
    • Early detection and identification of Candida and Aspergillus species in blood using molecular probes
    • Einsele H, Hebart H, Roller G et al. Early detection and identification of Candida and Aspergillus species in blood using molecular probes. J Clin Microbiol 1997; 35: 1353-1360.
    • (1997) J Clin Microbiol , vol.35 , pp. 1353-1360
    • Einsele, H.1    Hebart, H.2    Roller, G.3
  • 49
    • 84965190913 scopus 로고    scopus 로고
    • Galactomannan detection for invasive aspergillosis in immunocompromized patients
    • Leeflang M, Debets-Ossenkopp Y, Visser C et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008; 8: CD007394.
    • (2008) Cochrane Database Syst Rev , vol.8 , pp. CD007394
    • Leeflang, M.1    Debets-Ossenkopp, Y.2    Visser, C.3
  • 50
    • 0035869539 scopus 로고    scopus 로고
    • Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
    • Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
    • (2001) Blood , vol.97 , pp. 1604-1610
    • Maertens, J.1    Verhaegen, J.2    Lagrou, K.3    Van Eldere, J.4    Boogaerts, M.5
  • 51
    • 33646464211 scopus 로고    scopus 로고
    • Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis
    • Pfeiffer C, Fine J, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417-1427.
    • (2006) Clin Infect Dis , vol.42 , pp. 1417-1427
    • Pfeiffer, C.1    Fine, J.2    Safdar, N.3
  • 52
    • 77957765288 scopus 로고    scopus 로고
    • Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens
    • White P, Perry M, Loeffler J et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 2010; 48: 3753-3755.
    • (2010) J Clin Microbiol , vol.48 , pp. 3753-3755
    • White, P.1    Perry, M.2    Loeffler, J.3
  • 53
    • 0032856762 scopus 로고    scopus 로고
    • Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis
    • Maertens J, Verhaegen J, Demuynck H et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
    • (1999) J Clin Microbiol , vol.37 , pp. 3223-3228
    • Maertens, J.1    Verhaegen, J.2    Demuynck, H.3
  • 54
    • 58549118484 scopus 로고    scopus 로고
    • Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
    • Mengoli C, Cruciani M, Barnes R, Loeffler J, Donnelly J. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89-96.
    • (2009) Lancet Infect Dis , vol.9 , pp. 89-96
    • Mengoli, C.1    Cruciani, M.2    Barnes, R.3    Loeffler, J.4    Donnelly, J.5
  • 55
    • 84862219718 scopus 로고    scopus 로고
    • ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
    • Marchetti O, Lamoth F, Mikulska M, Viscoli CV, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-854.
    • (2012) Bone Marrow Transplant , vol.47 , pp. 846-854
    • Marchetti, O.1    Lamoth, F.2    Mikulska, M.3    Viscoli, C.V.4    Verweij, P.5    Bretagne, S.6
  • 57
    • 84856908797 scopus 로고    scopus 로고
    • b-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL3)
    • Lamoth F, Cruciani M, Mengoli C et al. b-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL3). Clin Infect Dis 2012; 54: 633-643.
    • (2012) Clin Infect Dis , vol.54 , pp. 633-643
    • Lamoth, F.1    Cruciani, M.2    Mengoli, C.3
  • 58
    • 46249126149 scopus 로고    scopus 로고
    • Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group
    • De Pauw B, Walsh T, Donnelly JP et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-1821.
    • (2008) Clin Infect Dis , vol.46 , pp. 1813-1821
    • De Pauw, B.1    Walsh, T.2    Donnelly, J.P.3
  • 59
    • 20444371963 scopus 로고    scopus 로고
    • Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay
    • Marr K, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-1769.
    • (2005) Clin Infect Dis , vol.40 , pp. 1762-1769
    • Marr, K.1    Laverdiere, M.2    Gugel, A.3    Leisenring, W.4
  • 60
    • 68949108384 scopus 로고    scopus 로고
    • Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophilcurve
    • Portugal R, Garinca M, Nucci M. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophilcurve. J Clin Oncol 2009; 27: 3849-3854.
    • (2009) J Clin Oncol , vol.27 , pp. 3849-3854
    • Portugal, R.1    Garinca, M.2    Nucci, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.